GSD NovaPrime® SARS-CoV-2 (COVID-19) Real-Time PCR (96 reactions)
跳转到英文网站GSD NovaPrime® SARS-CoV-2 (COVID-19) is a Multiplex Real-Time PCR with CE-IVD marking for the direct qualitative pathogen detection of the novel Coronavirus (SARS-CoV-2). Particularly in the early phase of a virus infection, the direct diagnostic of the pathogen is key.
The GSD NovaPrime® SARS-CoV-2 (COVID-19) RT-PCR is intended for the qualitative determination of SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2) genomic RNA extracted from human respiratory (nasal wash/swab, nasopharyngeal wash/swab, oropharyngeal swab and bronchoalveolar lavage) specimen types.
The assay simultaneously detects two target sequences inside the N gene. The multiplex PCR allows a streamlined workflow in one reaction and provides results in approximately 2 hours. An extraction/inhibition control and a positive control is included in the reagents.
The PCR assay demonstrates excellent performance with a 100 % Negative and Positive Percent Agreement (NPA, PPA) for all tested samples and no cross-reactivity with other common widely spread coronaviruses. The analytic sensitivity shows a limit of detection of 3.75 copies/reaction.
| SKU | PCOV6033 |
|---|---|
| No. of Reactions | 96 |
| Time to Result | Approximately 2 hours |
| PCR cycler platforms |
▪ ABI Prism® 7500 SDS (Applied BiosystemsTM) |